KIF2C/MCAK a prognostic biomarker and its oncogenic potential in malignant progression, and prognosis of cancer patients: a systematic review and meta-analysis as biomarker,Critical Reviews in Clinical Laboratory Sciences

当前位置： X-MOL 学术 › Crit. Rev. Clin. Lab. Sci. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

KIF2C/MCAK a prognostic biomarker and its oncogenic potential in malignant progression, and prognosis of cancer patients: a systematic review and meta-analysis as biomarker
Critical Reviews in Clinical Laboratory Sciences ( IF 10.0 ) Pub Date : 2024-02-12 , DOI: 10.1080/10408363.2024.2309933
Nina-Naomi Kreis ₁ , Ha Hyung Moon ₁ , Linda Wordeman ₂ , Frank Louwen ₁ , Christine Solbach ₁ , Juping Yuan ₁ , Andreas Ritter ₁

Affiliation

KIF2C/MCAK (KIF2C) is the most well-characterized member of the kinesin-13 family, which is critical in the regulation of microtubule (MT) dynamics during mitosis, as well as interphase. This syste...

更新日期：2024-02-13

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>